Search results
Dec 1, 2023 · Read the IARC Monographs Q&A for answers to commonly asked questions on the evaluation process. Note: In September 2022, four additional individual Group 1 agents were created by splitting up some existing agent groupings because not all agents in the groups had the same cancer sites with sufficient and limited evidence for cancer in humans ...
- List of Classifications
IARC Monographs on the Identification of Carcinogenic...
- List of Classifications by Cancer Site
IARC Monographs –. List of Classifications by Cancer Site....
- List of Classifications
Feb 24, 2015 · Shortly after IARC’s establishment, its parent entity, the World Health Organization (WHO), asked IARC to prepare a list of agents known to cause cancer in humans. IARC recognized the need for a systematic process to determine which agents should be listed.
- Neil Pearce, Aaron Blair, Paolo Vineis, Wolfgang Ahrens, Aage Andersen, Josep M. Anto, Bruce K. Arms...
- 2015
In general, the American Cancer Society does not determine if something causes cancer (that is, if it is a carcinogen). Instead, we rely on the determinations of other respected agencies, such as the International Agency for Research on Cancer (IARC, part of the World Health Organization) and the US National Toxicology Program (NTP).
Sep 9, 2019 · For nearly 50 years, the Monographs program of the International Agency for Research on Cancer (IARC) has been a premier global resource for identifying agents that can cause cancer. The identification of carcinogenic hazards is a necessary initial step in cancer prevention.
- Jonathan M Samet, Weihsueh A Chiu, Vincent Cogliano, Jennifer Jinot, David Kriebel, Ruth M Lunn, Fre...
- 2020
Oct 22, 2019 · ABSTRACT. Since the inception of the International Agency for Research on Cancer (IARC) in the early 1970s, the IARC Monographs Programme has evaluated more than 1000 agents with respect to carcinogenic hazard; of these, up to and including Volume 119 of the IARC Monographs, 120 agents met the criteria for classification as carcinogenic to humans (Group 1).
Interdisciplinary working groups of expert scientists review the published studies and assess the strength of the available evidence that an agent can cause cancer in humans. The principles, procedures, and scientific criteria that guide the evaluations are described in the Preamble to the IARC Monographs.
People also ask
Why did IARC create a list of agents that cause cancer?
How does the IARC select a carcinogenic agent?
When did IARC start determining which agents should be listed?
